New York, New York–(Newsfile Corp. – December 18, 2025) – DesignRush, a leading B2B platform, today released its list of the Top SEO Agencies for December 2025 as search teams adjust to another round of platform changes. The agency’s latest SEO roundup reported that Google has confirmed a new core update in the coming weeks, […]
Zagreb, Croatia–(Newsfile Corp. – December 18, 2025) – Tech consultancy Infinum‘s award-winning Dutch creative agency, Your Majesty – Part of Infinum, opened the gates of its Castle of Curiosity event series, a focused session on branding in the era of artificial intelligence. The event brought together industry professionals to explore practical approaches for maintaining brand
Trading resumes in: Company: Sierra Madre Gold and Silver Ltd. TSX-Venture Symbol: SM All Issues: Yes Resumption (ET): 8:00 AM CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. CIRO is the national
(NASDAQ:SLRX), The combined Company will move forward as Decoy Therapeutics, Inc. and trade on the NASDAQ Stock Market under the ticker “DCOY” effective in early January 2026 Company to focus on advancing lead antiviral programs, expanding platform validation and achieving multiple data milestones Strategic 2026 roadmap designed to accelerate development, expand pipeline breadth, and drive
Salarius Pharmaceuticals Announces Planned Corporate Name and Ticker Symbol Change to Decoy Therapeutics, Reflecting Strategic Pivot to Next-Generation Antiviral and Peptide-Conjugate Platform GlobeNewswire December 18, 2025 The combined Company will move forward as Decoy Therapeutics, Inc. and trade on the NASDAQ Stock Market under the ticker “DCOY” effective in early January 2026 Company to focus
Hardy Diagnostics, a leading manufacturer and distributor of culture media and diagnostic solutions for microbiology laboratories, proudly announces its strategic partnership with NEMIS Technologies, a Swiss-based innovator in rapid on-site pathogen detection. Through this exclusive collaboration, Hardy Diagnostics will introduce NEMIS's cutting-edge N-Light™ technology and advanced hygiene monitoring solutions to the North American market. https://mma.prnewswire.com/media/2848321/Hardy_Diagnostics_3005_COS_Official_Logo_Logo.jpg
NEW YORK, NY / ACCESS Newswire / December 18, 2025 / Levi & Korsinsky, LLP releases a Podcast regarding Telix Pharmaceuticals Ltd. (NASDAQ:TLX) class action securities lawsuit A Class Action lawsuit was filed on behalf of Telix Pharmaceuticals Ltd. investors who lost money as a result of alleged securities fraud between February 21, 2025 and
(TSX:MBX),(OTC US:MBXBF),(Other OTC:MBXBF), MISSISSAUGA, Ontario, Dec. 18, 2025 (GLOBE NEWSWIRE) — Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix(R)), a life sciences innovator, manufacturer, and exporter, reports results for its fiscal year and fourth quarter ended September 30, 2025 (“2025” and “Q4“) with revenues for those periods reflecting reduced antigen sales into China and cancellation
Microbix Reports Results for Q4 and Fiscal 2025 Full-Year Revenues of $18.6 million and Net Loss of $2.2 million GlobeNewswire December 18, 2025 MISSISSAUGA, Ontario, Dec. 18, 2025 (GLOBE NEWSWIRE) — Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix(R)), a life sciences innovator, manufacturer, and exporter, reports results for its fiscal year and fourth quarter
NEW YORK, NY / ACCESS Newswire / December 18, 2025 / Levi & Korsinsky, LLP releases a Podcast regarding Stride, Inc. (NYSE:LRN) class action securities lawsuit A Class Action lawsuit was filed on behalf of Stride, Inc. investors who lost money as a result of alleged securities fraud between October 22, 2024 and October 28,